Antibodies against protein Z and fetal loss: current perspectives.

T Dörner, B Hoppe, A Salama, A Pruss, H Kiesewetter

Journal: Clinical and experimental medicine 2005;5(2):50-4

PMID: 16096853

Abstract

Protein Z (PZ) is a vitamin K-dependent plasma protein that serves as a cofactor for the inactivation of factor Xa. A number of investigators found low PZ levels in patients with haemorrhagic as well as thromboembolic diseases, although there is no clear evidence of a pathogenic link between PZ deficiency and these clinical disorders. Nevertheless, low PZ levels have been found in association with early fetal losses, especially those occurring before the 15th week of gestation and in patients with detectable antiphospholipid and anti-PZ antibodies. The current diagnostic relevance and therapeutic consequences of these parameters will be discussed.

Address: Coagulation Unit, Institute of Transfusion Medicine, Charité University Medicine Berlin, Free University and Humboldt University Berlin, Schumannstrasse 20/21, D-10098, Berlin, Germany. [email protected]

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.